$AHCO

AdaptHealth Corp.

No enriched coverage for $AHCO in the last 7 days.

No SEC Form 4 filings for $AHCO in the last 30 days.

Med

Why AdaptHealth (AHCO) Shares Are Sliding Today

AdaptHealth (AHCO) shares fell 8.5% after the company reported disappointing Q1 2026 results, including a significant earnings miss and worsening profitability despite a revenue beat. The GAAP loss per share was $0.12, far worse than analyst estimates. Although revenue increased by 5.4% to $819.8 million, the operating margin contracted sharply, and the company experienced increased cash burn, leading to investor concerns about rising costs and operational efficiency.

Is It Time To Reassess AdaptHealth (AHCO) After A 60% One Year Rally?

AdaptHealth (AHCO) has seen a significant 60% rally over the past year, prompting a reassessment of its current valuation. A Discounted Cash Flow (DCF) analysis suggests the stock is undervalued by 64.0%, while its P/S ratio indicates a modest discount compared to a proprietary fair ratio. The article also presents bullish and bearish narratives, with fair values ranging from US$9.50 to US$17.00 per share, offering investors different perspectives on the company's future.

Vanguard Group Inc. Has $100.93 Million Stock Holdings in AdaptHealth Corp. $AHCO

Vanguard Group Inc. has scaled back its stake in AdaptHealth Corp. by 4.9% in the third quarter, now holding 11.28 million shares valued at approximately $100.93 million. This comes as AdaptHealth reported a significant earnings miss despite exceeding revenue estimates, leading to a negative net margin. The company currently has a "Moderate Buy" consensus rating from analysts, with institutional ownership remaining high at 82.67%.